£172.50

Springer Biology and Management of Lung Cancer: 11 (Cancer Treatment and Research)

Price data last checked 52 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£173 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 39 days · 39 data points (no recent data)

Historical
Generating forecast…
£175.34 £172.22 £172.90 £173.58 £174.26 £174.94 £175.62 23 April 2026 02 May 2026 12 May 2026 21 May 2026 31 May 2026

Price Distribution

Price distribution over 39 days • 3 price levels

Days at Price
Current Price
30 days · current 4 days 5 days 0 8 15 23 30 £173 £174 £175 Days at Price

Price Analysis

Most common price: £173 (30 days, 76.9%)

Price range: £173 - £175

Price levels: 3 different prices over 39 days

Description

Lung cancer remains an extremely difficult neoplasm to treat effectively. A large part of our lack of success in dealing with these patients is related to our empiric therapeutic attempts. Slowly our basic understanding of the lung cancers is improving and techniques are becoming available to allow us to better understand the biology of these neoplasms. This volume reviews several areas of interest in regard to the biologic behavior and characteris of lung cancer. tics Chapters deal with the in vitro growth of small cell lung cancer, the inves tigation of growth factors in human lung cancer, the production of mono clonal antibodies against lung cancer and the application and potential use fulness of the human tumor cloning assay in lung cancer management. These avenues of investigation are likely to establish a more scientific basis on which more rational therapy can be designed. Carney and associates have established several continuous small cell lung cancer cell lines in their laboratory. The amine precursor uptake and decar boxylation (APUD) properties of this neoplasm have been confirmed by demonstrating the presence of neurosecretory granules and high levels of the APUD enzyme L-dopa decarboxylase. In addition, several new markers have been documented including bombesin, creatine-kinase BB and neuron specific enolase. These tumor products along with others may be useful serum markers in patients with small cell lung cancer.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
12 October 2011
Listed Since
21 December 2012

Barcode

No barcode data available

Similar Products You Might Like

Molecular Targeted Therapy of Lung Cancer
85% match

Molecular Targeted Therapy of Lung Cancer

Springer

£113.70 06 Jun 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
84% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£65.39 26 May 2026
Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice
84% match

Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice

Springer

£80.64 25 May 2026
Lung Cancer: Basic and Clinical Aspects: Basic and Clinical Aspects: 28 (Cancer Treatment and Research)
84% match

Lung Cancer: Basic and Clinical Aspects: Basic and Clinical Aspects: 28 (Cancer Treatment and Research)

Springer

£129.69 06 Jun 2026
Lung Cancer and Autoimmune Disorders: 833 (Advances in Experimental Medicine and Biology, 833)
83% match

Lung Cancer and Autoimmune Disorders: 833 (Advances in Experimental Medicine and Biology, 833)

Springer

£76.38 25 May 2026
Cancer of the Lung: From Molecular Biology to Treatment Guidelines (Current Clinical Oncology)
83% match

Cancer of the Lung: From Molecular Biology to Treatment Guidelines (Current Clinical Oncology)

Humana

£107.98 30 May 2026
Lung Cancer and Autoimmune Disorders: 833 (Advances in Experimental Medicine and Biology, 833)
83% match

Lung Cancer and Autoimmune Disorders: 833 (Advances in Experimental Medicine and Biology, 833)

Springer

£72.78 01 Jun 2026
Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)
83% match

Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)

Springer

£113.76 21 May 2026
The Molecular Genetics of Lung Cancer
83% match

The Molecular Genetics of Lung Cancer

Springer

£80.64 08 Jun 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
83% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£148.53 26 May 2026
Management of Lung Cancer in Older People
82% match

Management of Lung Cancer in Older People

Springer

£80.64 20 May 2026
Management of Lung Cancer in Older People
82% match

Management of Lung Cancer in Older People

Springer

£103.24 18 May 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
82% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£163.85 31 May 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
82% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 25 May 2026
Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)
82% match

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Springer

£113.76 11 Jun 2026
Progress and Perspective in the Treatment of Lung Cancer (Medical Radiology)
82% match

Progress and Perspective in the Treatment of Lung Cancer (Medical Radiology)

Springer

£107.98 01 Jun 2026
Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)
82% match

Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)

Springer

£164.68 03 Jun 2026
Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)
82% match

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Springer

£149.64 25 May 2026
Inflammation and Lung Cancer
82% match

Inflammation and Lung Cancer

Springer

£76.30 17 Jun 2026
Lymphangiogenesis in Cancer Metastasis: 13 (Cancer Metastasis - Biology and Treatment, 13)
81% match

Lymphangiogenesis in Cancer Metastasis: 13 (Cancer Metastasis - Biology and Treatment, 13)

Springer

£113.76 11 May 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
81% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£163.14 30 May 2026
Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)
81% match

Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)

Springer

£113.94 01 Jun 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
81% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£111.46 31 May 2026
Lung Cancer, An Issue of Hematology/Oncology Clinics of North America: Volume 37-3 (The Clinics: Internal Medicine, Volume 37-3)
81% match

Lung Cancer, An Issue of Hematology/Oncology Clinics of North America: Volume 37-3 (The Clinics: Internal Medicine, Volume 37-3)

Elsevier

£72.18 04 Jun 2026